Xortx Therapeutics Inc. valuation and forecast
Explore the models for Xortx Therapeutics Inc., adjust their assumptions and compare your own valuation with the platform's.
Stock price today
Loading chart…
Third-party market data · may be delayed
Fair value per share
Under review: share count (0m) is 0.016x the cover-page count (7m).
Price vs value
Under review: share count (0m) is 0.016x the cover-page count (7m). We'll show the comparison once resolved.
Price history
Loading chart…
Third-party market data · may be delayed
XRTX valuation questions
- How does Fundamentalytics value Xortx Therapeutics Inc.?
- We use the models that fit Xortx Therapeutics Inc.'s business and available financial data. Each model has its own assumptions and data requirements. The calculator explains which models are available and lets you adjust their inputs.
Data: SEC EDGAR filings, retrieved November 1, 2026. Method: how we value companies. Disclosures: research and recommendations disclosure. Back to Xortx Therapeutics Inc.